Key result
Targeting collagen turnover regulators offers potential novel therapeutic strategies to prevent in-stent restenosis.
Answers are grounded in this paper and cite their sources.
Events contributing to restenosis after coronary interventions include platelet aggregation, inflammatory cell infiltration, growth factor release, and accumulation of smooth muscle cells (SMCs) and extracellular matrix (ECM). The ECM is composed of various collagen subtypes and proteoglycans and over time constitutes the major component of the mature restenotic plaque. The pathophysiology of collagen accumulation in the ECM during arterial restenosis is reviewed. Factors regulating collagen synthesis and degradation, including various cytokines and growth factors involved in the process, may be targets for therapies aimed at prevention of in-stent restenosis.
No takes yet. Share an insight, caveat, or question.
Osherov et al. (2011) conducted a review in Arterial restenosis. Therapies targeting collagen synthesis and degradation was evaluated. Factors regulating collagen synthesis and degradation, including various cytokines and growth factors, may serve as novel targets for therapies aimed at preventing in-stent restenosis.
Synapse has enriched 10 related papers. Consider them for comparative context: